about
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug ...
Read More
11.02
0.14
(1.29%)
332.2K
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Delcath Systems Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..